World of DTC Marketing

AUGUST 7, 2022

According to a 2021 study , 1.1 million deaths—including one in two of those under 65, thanks in large part to our abysmal health care system—”would have been averted if the U.S. had the mortality rates of other wealthy nations. One in three GoFundMe campaigns is now for healthcare-related costs, and it’s getting worse. The passage of the Inflation Control bill is an excellent first step in limiting high drug costs, but our healthcare system is still built for profit at the expense

Insurance 263

Insurance Doctors Government Physicians 263

pharmaphorum

AUGUST 12, 2022

Half a million people in the UK with conditions like blood cancer that prevents them being protected from COVID-19 vaccines are facing another winter shielding, because the government has shelved plans to offer treatment with AstraZeneca’s antibody therapy Evusheld. That’s the position of multiple patient organisations, clinicians and medical groups, who have criticised the Department of Health’s decision to defer procurement of Evusheld supplies until cost-effectiveness agency

Government 145

Government Patients Medicine Healthcare 145

Pharmaceutical Technology

AUGUST 12, 2022

In June this year, it was announced that the US Food and Drug Administration (FDA) had granted UK-based OxfordVR a breakthrough device designation for its gameChangeVR treatment to deliver immersive cognitive behaviour therapy (CBT) to people suffering from schizophrenia and other mental illnesses. The FDA’s breakthrough device programme is for medical devices or device-led combination products that provide more effective treatment or diagnosis of diseases.

Food and Drug Administration 141

Food and Drug Administration Pharmacology Side effects Physicians 141

PharmExec

AUGUST 10, 2022

The technology is not just about digital enablement anymore.

Patients 141

Patients 141

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

World of DTC Marketing

AUGUST 10, 2022

CPG marketers are trying to maintain market share amid price increases and smaller product sizes, leading to a more significant jump in consumerism. But, in pharma marketing, the changes affect every product category. Consumers share more information online than ever as inflation cuts into their disposable income. I’ve seen posts on everything from opinions on detergents to the best and more inexpensive ice cream.

Marketing 252

Marketing Media Side effects Pharma 252

pharmaphorum

AUGUST 8, 2022

A study of a mobile health app used to support patients hospitalised with heart failure has concluded that it provided a modest improvement in quality-of-life scores, as well as better clinical outcomes. The finding comes from the large-scale CONNECT-HF cluster study, which looked at various patient engagement and education interventions to see if they could help patients with heart failure do better after discharge from hospital.

Medical 145

Medical Patients Doctors Prospecting 145

PharmExec

AUGUST 10, 2022

Failed efforts do not overshadow field’s progress, resolve.

Medicine 132

Medicine 132

World of DTC Marketing

AUGUST 8, 2022

Consumers have changed their shopping behavior due to the pandemic, and some of those changes are relevant for pharma marketers. The days of someone seeing an ad for a prescription drug and rushing to ask their doctor about it have replaced the quest for more information, usually online. CPG brands have finally admitted that consumers are changing how they purchase products and brands.

Side effects 226

Side effects Media Marketing Doctors 226

Pharmaceutical Technology

AUGUST 10, 2022

The US Food and Drug Administration (FDA) has granted Fast-Track designation to Relmada Therapeutics’ REL-1017 as a single agent to treat major depressive disorder (MDD). A new chemical entity and NMDA receptor (NMDAR) channel blocker, REL-1017 acts on hyperactive channels while preserving physiological glutamatergic neurotransmission. Presently, the therapy is being analysed in late-stage studies.

Food and Drug Administration 119

Food and Drug Administration FDA Safety Food 119

MedCity News

AUGUST 8, 2022

An expert industry observer said CVS Health’s move into primary care is both offensive and defensive, but perhaps more importantly a natural evolution of a company with such a large healthcare footprint.

Healthcare 137

Healthcare Healthcare 137

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

PharmExec

AUGUST 10, 2022

Curative-type therapies offer great hope in further transforming treatments for cancer and other diseases, but addressing the economics of these products—and ultimately the cost-benefit equation—is daunting. What is being done to smooth the path for pricing and reimbursement?

119

119

Pharmaceutical Commerce

AUGUST 11, 2022

Pharmaceutical distribution today is anything but monolithic. While companies in this space are grappling with issues ranging from inflation and supply chain disruption to workforce scarcity and DSCSA implementation, there’s still plenty of room for smaller players to stake out part of the terrain to call their own.

Distribution 116

Distribution Pharmaceutical Distribution Pharma Pharmaceutical 116

PharmaVoice

AUGUST 10, 2022

Miruna Sasu is on a mission to use real world data to help wipe out cancer. She believes this audacious goal is within reach, and as president and CEO of COTA, she is inspiring her team to create a “path to care” for oncology patients.

Patients 116

Patients 116

MedCity News

AUGUST 7, 2022

Nonhuman primates will be critical to our efforts to understand the long-term effects of Covid-19. Yet scientists conducting critical research have faced harassment and threats.

132

132

Advertisement

PharmExec

AUGUST 10, 2022

Marie-France Tschudin, president, innovative medicines international, and chief commercial officer at Novartis, taps into life lessons to help bring therapies to people in novel ways­.

Medicine 116

Medicine 116

Copyright Clearance Center

AUGUST 9, 2022

August 9, 20 22 – Danvers, Mass. – CCC , a leader in advancing copyright, accelerating knowledge, and powering innovation, is now offering subscriptions to select publishers including the JAMA Network and the New England Journal of Medicine (NEJM) through CCC’s advanced content workflow solution, RightFind , to meet the needs of researchers in organizations with fewer than 500 employees.

Networking 116

Networking Medicine Physicians Education 116

European Pharmaceutical Review

AUGUST 11, 2022

The Frost & Sullivan Institute stated that it is proud to present Samsung Biologics with the 2022 Enlightened Growth Leadership Award for not only demonstrating growth excellence but also social responsibility. In announcing the award, the Institute asserted that it “believes that all organisations must either create or become part of a solution that addresses threats to humanity,” highlighting Samsung’s strong environmental, social and governance (ESG) and sustainability initiatives the rea

Manufacturing 111

Manufacturing Government Healthcare Healthcare 111

MedCity News

AUGUST 9, 2022

Commercial insurers’ practices, such as prior authorization and white bagging, are needed to reduce costs for patients, said Kristine Grow, senior vice president of communications at AHIP.

Insurance 126

Insurance Patients Pharma 126

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

pharmaphorum

AUGUST 8, 2022

Pfizer’s reported interest in acquiring sickle cell disease specialist Global Blood Therapeutics (GBT) has been confirmed, with the $68.50-per-share deal valuing GBT at $5.4 billion. As we reported this morning, the deal gives Pfizer already-approved SCD therapy Oxbryta (voxelator) – which industry watchers reckon could see a dramatic uptick in sales with Pfizer’s marketing muscle – plus a phase 3 antibody candidate, a phase 1 follow-up to Oxbryta that could offer improved dosing.

Marketing 111

Marketing Sales Pharma FDA 111

Medgadget

AUGUST 11, 2022

Engineers at MIT have created an ultrasound patch that can provide long-term ultrasound imaging of internal organs and structures. The device contains a rigid piezoelectric probe array and uses an underlying layer of elastomer-covered hydrogel in lieu of the gel applied to the skin during conventional ultrasound procedures. At just the size of a postage stamp, the ultrasound patch is highly portable and less expensive than conventional ultrasound technologies.

Engineering 108

Engineering Patients Medicine 108

Pharmaceutical Technology

AUGUST 12, 2022

The US Food and Drug Administration (FDA) has granted approval for Daiichi Sankyo and AstraZeneca ’s Enhertu (fam-trastuzumab deruxtecan-nxki) to treat unresectable or metastatic non-small cell lung cancer (NSCLC) in adults. The treatment is indicated for such patients whose tumours have activating HER2 (ERBB2) mutations and previously received systemic therapy. .

Food and Drug Administration 105

Food and Drug Administration FDA Safety Engineering 105

MedCity News

AUGUST 10, 2022

Vector BioPharma has launched from the biotech startup incubator of Versant Ventures, which is backing the company with a $30 million Series A financing. Vector is developing virus-like particles with the capability to deliver large payloads of genetic medicines to a wide range of tissues.

Biopharma 122

Biopharma Medicine Pharma 122

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

pharmaphorum

AUGUST 9, 2022

AI could address the most significant issue in drug discovery, finds Ben Hargreaves, and also offers the potential to use tissue samples to create precision medicine for specific patient groups. The scale of the challenge. Cancer is the second leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, according to the World Health Organization.

Doctors 111

Doctors Patients Medicine Pharma 111

Medgadget

AUGUST 11, 2022

Researchers at INSERM (Institut national de la santé et de la recherche médicale) in France, and collaborators, have developed a DNA-based nanorobot called the Nano-winch. The tiny creation is made using DNA molecules and a “DNA Origami” approach. The tiny robot is so small that it can land on a cell surface and interact with ‘mechanoreceptors’ that the cell uses to sense mechanical forces acting on it.

Medical 107

Medical Medicine 107

PM360

AUGUST 9, 2022

PM360 asked life sciences industry experts with knowledge about improving adherence to medication to share the latest trends and approaches being used and to tell us how better data and monitoring can help solve this issue. Specifically, we wanted to know: What are the current biggest trends in how the life sciences industry is approaching ways to improve medication adherence?

Medical 105

Medical Patients Electronics Healthcare 105

MedCity News

AUGUST 7, 2022

The increases in enrollment are likely because of changes in the economy, policy changes like Medicaid expansion in the Affordable Care Act and the temporary continuous enrollment requirement from the Family First Coronavirus Response Act, the report said. .

Insurance 122

Insurance 122

Advertiser: ZoomInfo

Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr

Competition

pharmaphorum

AUGUST 11, 2022

GSK, its consumer health spin-off Haleon and Sanofi could be on the hook for billions of dollars in potential damages over Zantac, a gastrointestinal drug pulled from the market in 2020 after it was linked to cases of cancer. That’s the conclusion of analysts at Morgan Stanley, Deutsche Bank and UBS, who have all issued research notes drawing attention to the issue, which has remained largely off the radar since sales of Zantac (ranitidine) were halted.

Sales 105

Sales Prescription FDA Marketing 105

Pharmaceutical Technology

AUGUST 8, 2022

AstraZeneca and Daiichi Sankyo ’s Enhertu (trastuzumab deruxtecan) has received expanded approval from the US Food and Drug Administration (FDA) to treat adults with unresectable or metastatic HER2-low (IHC 1+ or IHC 2+/ISH-) breast cancer. The treatment is indicated for patients who have previously received chemotherapy in the metastatic setting or recurred during or within six months of receiving adjuvant chemotherapy.

Food and Drug Administration 105

Food and Drug Administration FDA Safety Food 105

Pharmaceutical Commerce

AUGUST 11, 2022

Exploring the competitive and unique offerings in three of the US’s lower-cost economic development regions—and how success in these areas has been boosted by COVID.

Competition 105

Competition 105

MedCity News

AUGUST 11, 2022

Many employed Americans misunderstand their health insurance plans, and 72% want someone to just tell them what the best plan is for their specific needs, the survey found.

Insurance 122

Insurance 122

Advertisement

Distribution